Today: 8 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

BHP Group Ltd Stock (ASX:BHP, NYSE:BHP): Latest News, Forecasts and Analyst Views as of 21 December 2025

BHP Group Ltd Stock (ASX:BHP, NYSE:BHP): Latest News, Forecasts and Analyst Views as of 21 December 2025

BHP shares closed near the top of their 2025 range, last trading at A$44.36 in Australia and $59.32 in New York. The company confirmed a US$2 billion infrastructure funding deal with BlackRock’s GIP, keeping 51% control of Western Australia Iron Ore’s power assets. The agreement is expected to complete by late FY2026, pending regulatory approval. BHP reiterated plans to boost iron ore capacity to 305 million tonnes per year.
21 December 2025
Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston shares plunged nearly 26% Friday after management warned of continued discounting and higher international costs despite beating Q2 FY2026 earnings expectations. Net sales rose 1% to $1.618 billion, with an 8% volume gain offset by an 8% drop in price/mix. The company said margin pressure may persist into the second half of the year.
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) shares fell 11.5% to $80.04 on Dec. 20, 2025, after a STAT News report raised doubts about the effectiveness of its lead drug bitopertin and the FDA’s fast-track voucher process. The stock traded between $71.46 and $94.60 on heavy volume after Truist Securities cited the report, fueling concerns about the viability of accelerated approval.
20 December 2025
Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital shares jumped 16.53% to $27.85 on Friday, Dec. 19, rebounding after a midweek drop tied to debt concerns in the AI data center sector. The rally followed news of a $100 million development loan facility with Macquarie Group and renewed optimism in AI infrastructure stocks after Micron’s results.
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin shares jumped 17.7% to $61.15 Friday after announcing a $4.8 billion all-cash deal to acquire Amicus Therapeutics at $14.50 per share. The acquisition adds two marketed rare-disease drugs and a Phase 3 asset, and resolves U.S. patent litigation over Galafold, delaying generic entry to 2037. BioMarin expects the deal to close in Q2 2026 and be accretive to earnings within a year.
Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival shares jumped 9.8% to $31.12 Friday after the company reported record 2025 profit of $2.8 billion and revenue of $26.6 billion. The board reinstated a quarterly dividend at $0.15 per share, the first since 2020. Carnival also proposed unifying its dual-listed structure and moving its legal domicile to Bermuda. Guidance for 2026 calls for further earnings growth.
Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab shares jumped 17.69% to close at $70.52 on December 19 after winning an $816 million U.S. Space Development Agency contract to build 18 missile-defense satellites. The award, part of a $3.5 billion program, marks Rocket Lab’s largest deal and positions it as a prime contractor alongside Lockheed Martin, Northrop Grumman, and L3Harris.
20 December 2025
Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

Ondas Holdings shares surged 18.2% to $9.22 on December 19, with trading volume hitting 125 million. The move followed a series of defense-focused announcements, including a new COO appointment and the completed acquisition of Roboteam. Analyst coverage has increased, while SEC filings show new share issuance and a significant non-cash charge.
Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics shares surged 20.8% to $25.55 on December 19, 2025, amid heavy trading and technical breakout signals. The move follows recent investor conference appearances and ongoing focus on late-stage neuromuscular and cardiovascular drug programs. As of September 30, the company reported $563.3 million in cash and a Q3 net loss of $40.7 million.
CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave shares surged 22.5% to about $83 in heavy trading after Citigroup resumed coverage with a Buy rating and the U.S. Department of Energy named the company as a Genesis Mission partner. Citi lowered its price target to $135 and flagged “High Risk,” citing strong demand but operational challenges. The stock had dropped 65% from its June high after its March IPO.
Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

BioMarin Pharmaceutical agreed to acquire Amicus Therapeutics in an all-cash deal valued at about $4.8 billion, offering $14.50 per share. Amicus stock jumped roughly 30% to $14.18 on heavy volume, trading just below the bid as investors assess deal closure risks. Both boards approved the transaction, with closing targeted for Q2 2026 pending shareholder and regulatory approvals.
DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

Trump Media & Technology Group announced an all-stock merger with nuclear fusion firm TAE Technologies, valuing the deal at over $6 billion. DJT shares surged more than 40% on Dec. 18, trading around $16 amid high volatility. The combined company will split ownership evenly between shareholders and target a utility-scale fusion plant. Trump Media CEO Devin Nunes and TAE’s Michl Binderbauer will serve as co-CEOs.
Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace shares jumped 22.82% on Dec. 19 to $24.65 after new analyst coverage from KeyBanc, following an 8.31% gain the previous day. The stock remains about 45% below its August IPO price of $45, despite volatile swings. KeyBanc cited early progress but flagged ongoing risks and a long path to profitability. Firefly raised $868 million in its IPO.
20 December 2025
Saudi Stock Exchange (Tadawul) Update on 20 Dec 2025: TASI Rebounds From Two‑Year Low as Oil, Rate Cuts and IPO Sentiment Shape 2026

Saudi Stock Exchange (Tadawul) Update on 20 Dec 2025: TASI Rebounds From Two‑Year Low as Oil, Rate Cuts and IPO Sentiment Shape 2026

The Tadawul All Share Index closed at 10,450.27 on December 18, up 0.35% after hitting a more than two-year low the previous day. November saw a 9.1% drop, the steepest monthly decline in three years, with the index down about 12% year-to-date. Market sentiment remains sensitive to oil price weakness and domestic monetary conditions.
20 December 2025
Mexico Stock Exchange News (Dec. 20, 2025): BMV Holds Near 64,000 as Banxico Cuts to 7%, Volaris-Viva Merger Sparks Rally, and 2026 IPC Forecasts Firm Up

Mexico Stock Exchange News (Dec. 20, 2025): BMV Holds Near 64,000 as Banxico Cuts to 7%, Volaris-Viva Merger Sparks Rally, and 2026 IPC Forecasts Firm Up

Mexico’s S&P/BMV IPC closed Friday at 63,966.98, up 0.25% for the day but down 1.15% for the week, marking its second weekly decline in three weeks. Volaris surged after news of a planned merger with Viva Aerobus, while Televisa and TEAK fell sharply. The index remains up for December and on track for one of its strongest years in over a decade.
20 December 2025
São Paulo Stock Exchange (B3) Outlook: Ibovespa Near 158,000 After Brazil’s 2026 Budget Approval as Selic Rate-Cut Bets and Election Politics Drive 2026 Forecasts

São Paulo Stock Exchange (B3) Outlook: Ibovespa Near 158,000 After Brazil’s 2026 Budget Approval as Selic Rate-Cut Bets and Election Politics Drive 2026 Forecasts

Brazil’s Ibovespa closed higher for a second day on Friday at 158,473.02, but ended the week down 1.4%. Trading was volatile, with banks like Itaú Unibanco and Bradesco leading gains and R$32.3 billion in volume. Congress approved the 2026 budget, projecting a primary surplus of 34.5 billion reais, the first under Lula’s current term. Investors remain focused on interest rate timing and political risks.
20 December 2025
Johannesburg Stock Exchange (JSE) Update: All Share at 114,850, ETFs Near R250bn, and the 2026 Outlook (as of 20 Dec 2025)

Johannesburg Stock Exchange (JSE) Update: All Share at 114,850, ETFs Near R250bn, and the 2026 Outlook (as of 20 Dec 2025)

The FTSE/JSE All Share closed at 114,850 on December 19, just below its 52-week high of 115,716.46, with a one-year gain of nearly 36%. Headline inflation eased to 3.5% in November, and markets expect South Africa’s central bank to cut rates in 2026. The JSE’s recent gains have been fueled by precious metals, a stronger rand, and new ETF and tech listings.
20 December 2025
Singapore Exchange (SGX) in Focus: Latest News, IPO Forecasts and 2026 Outlook as Singapore Pushes a Market Revival

Singapore Exchange (SGX) in Focus: Latest News, IPO Forecasts and 2026 Outlook as Singapore Pushes a Market Revival

Singapore Exchange reported November securities market turnover up 18% year-on-year to S$35.5 billion, with daily average value at S$1.8 billion. Index heavyweights and REITs led flows, while the Straits Times Index hit a record 4,575.91. FTSE China A50 Index Futures open interest rose to 1.07 million contracts. GIFT Nifty 50 Futures and Options open interest reached a record US$16.5 billion notional.
20 December 2025
1 408 409 410 411 412 584
Go toTop